HTX 0.00% 0.1¢ healthlinx limited

HealthLinx LimitedABN 88 098 640 352576 Swan Street Richmond VIC...

  1. 872 Posts.
    HealthLinx Limited
    ABN 88 098 640 352
    576 Swan Street Richmond VIC 3121
    Telephone: +61 3 9208 4200 I Facsimile: +61 3 9208 4201
    www.healthlinx.com.au
    OvPlex™ patent granted in Singapore
    6 July 2012: HealthLinx Limited (ASX:HTX) has secured the grant of the patent application
    protecting its OvPlex™ ovarian cancer diagnostic product in Singapore, the fourth jurisdiction to
    secure patent coverage. Previously, patents have been granted in Australia, the United Kingdom
    and Hong Kong.
    The granting of this patent in Singapore is a significant milestone for the company; with Singapore
    one of the first international territories to market OvPlex™.
    OvPlex™ was launched in Singapore by HeatlhLinx’s distributor, INEX Innovations Exchange in
    October 2010 and has been well received in the market with expected sales targets exceeded by
    approximately 30%.
    HealthLinx’s incoming General Manager, Ms Vanessa Waddell stated that “the granting of the
    patent in Singapore provides INEX with the mechanism to protect market exclusivity for OvPlex™,
    an important outcome for the ongoing growth in OvPlex™ sales in this territory. Furthermore, this
    achievement strengthens our relationship with INEX as they lead the expansion of OvPlex™ sales
    across other Asian territories, including Malaysia and India.” “This patent is also a significant
    addition to HealthLinx’s growing patent portfolio,” Waddell concluded.
    Singapore Patent Number 165517 titled “An Assay to detect a Gynecological condition” draws
    priority from the Australian Patent Applications filed on 23rd April 2008 and 1st October 2008. The
    patent was granted to HealthLinx with the inventors, Dominic Autelitano, Tracey Edgell, Nick
    Gatsios and Leodevico Ilag named on the Patent.
    Enquiries
    Nick Gatsios (HealthLinx Limited) +61 3 9208 4200
    Rudi Michelson (Monsoon Communications) +61 3 9620 3333
 
watchlist Created with Sketch. Add HTX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.